Tiziana Life Sciences KOL Event - Foralumab Clinical Update in Multiple Sclerosis; A Landmark Study with Intranasal Immunotherapy featuring 4 Key Opinion Leaders Mar 14 2022 at 11:00 AM EDT KOL Event: Foralumab Clinical Update in Multiple Sclerosis Webcast link Supporting Materials KOL Event: Foralumab Clinical Update in Multiple Sclerosis 3.5 MB
